Journal article
Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations
Abstract
Induced pluripotent stem cell reprogramming has provided critical insights into disease processes by modeling the genetics and related clinical pathophysiology. Human cancer represents highly diverse genetics, as well as inter- and intra-patient heterogeneity, where cellular model systems capable of capturing this disease complexity would be invaluable. Acute myeloid leukemia (AML) represents one of most heterogeneous cancers and has been …
Authors
Lee J-H; Salci KR; Reid JC; Orlando L; Tanasijevic B; Shapovalova Z; Bhatia M
Journal
Stem Cells, Vol. 35, No. 9, pp. 2095–2102
Publisher
Oxford University Press (OUP)
Publication Date
September 1, 2017
DOI
10.1002/stem.2655
ISSN
1066-5099